INTRODUCTION: Assistive technologies (ATs) offer significant potential to improve the quality of life for individuals with Amyotrophic Lateral Sclerosis (ALS). This study explores the concept of integrated user value (IUV), focusing on five key aspects: quality, user experience, cost-effectiveness, safety, and accessibility. Understanding IUV is crucial for enhancing the development and deployment of ATs in ALS disease management. METHODS: A systematic search approach was utilized to collect data from Facebook ALS support groups, comprising posts from individuals with ALS and their caregivers. Using a predefined set of keywords, 416 posts were analyzed. The posts were categorized based on the five aspects of IUV, and an in-depth content analysis was conducted to explore patterns, challenges, and experiences associated with AT usage. RESULTS: The analysis revealed significant challenges across all aspects of IUV. Quality and user experience were interlinked, with users frequently citing inadequate designs and unmet customization needs. Cost-effectiveness was a key concern, with high costs and limited insurance coverage contributing to financial strain. Accessibility issues, including delays in acquiring devices and insufficient public facilities, further highlighted systemic challenges. Safety concerns emphasized the need for personalized and intuitive AT designs. DISCUSSION: The findings underscore the importance of a holistic approach to AT development, integrating all five aspects of IUV. Recommendations include enhancing product quality, ensuring affordability, prioritizing user-centered design, and addressing accessibility gaps. Collaboration between AT designers, healthcare providers, and policymakers is essential to optimize AT value and improve the quality of life for individuals with ALS and their caregivers.

Department of Economics University of Hradec Králové Hradec Králové Czechia

Department of Management University of Hradec Králové Hradec Králové Czechia

See more in PubMed

Eicher C, Kiselev J, Brukamp K, Kiemel D, Spittel S, Maier A, et al. . Experiences with assistive technologies and devices (ATD) in patients with amyotrophic lateral sclerosis (ALS) and their caregivers. Technol Disabil. (2019) 31:203–15. doi: 10.3233/TAD-190227 DOI

Bachmann P, Hruska J. Alzheimer caregiving problems according to ADLs: evidence from Facebook support groups. Int J Environ Res Public Health. (2022) 19:6423. doi: 10.3390/ijerph19116423, PMID: PubMed DOI PMC

Raj EX, Daniels DE, Thomson PE. Facebook groups for people who stutter: an extension of and supplement to in-person support groups. J Commun Disord. (2023) 101:106295. doi: 10.1016/j.jcomdis.2022.106295, PMID: PubMed DOI

Caron J, Light J. “My world has expanded even though I’m stuck at home”: experiences of individuals with amyotrophic lateral sclerosis who use augmentative and alternative communication and social media. Am J Speech Lang Pathol. (2015) 24:680–95. doi: 10.1044/2015_AJSLP-15-0010, PMID: PubMed DOI

Boot FH, Owuor J, Dinsmore J, MacLachlan M. Access to assistive technology for people with intellectual disabilities: a systematic review to identify barriers and facilitators: access to assistive technology. J Intellect Disabil Res. (2018) 62:900–21. doi: 10.1111/jir.12532, PMID: PubMed DOI

Debeuf R, Fobelets M, Vaneyghen J, Naets B, Minnaert B, De Wachter E, et al. . Healthcare professionals’ perspectives on development of assistive technology using the comprehensive assistive technology model. Assist Technol. (2023) 36:51–9. doi: 10.1080/10400435.2023.2202713, PMID: PubMed DOI

Smith RO, Scherer MJ, Cooper R, Bell D, Hobbs DA, Pettersson C, et al. . Assistive technology products: a position paper from the first global research, innovation, and education on assistive technology (GREAT) summit. Disabil Rehabil Assist Technol. (2018) 13:473–85. doi: 10.1080/17483107.2018.1473895, PMID: PubMed DOI

Sorgini F, Caliò R, Carrozza MC, Oddo CM. Haptic-assistive technologies for audition and vision sensory disabilities. Disabil Rehabil Assist Technol. (2018) 13:394–421. doi: 10.1080/17483107.2017.1385100, PMID: PubMed DOI

Mustafa HR, Short M, Fan S. Social support exchanges in Facebook social support group. Procedia Soc Behav Sci. (2015) 185:346–51. doi: 10.1016/j.sbspro.2015.03.449 DOI

Sweet KS, LeBlanc JK, Stough LM, Sweany NW. Community building and knowledge sharing by individuals with disabilities using social media. J Comput Assist Learn. (2020) 36:1–11. doi: 10.1111/jcal.12377 DOI

Hobson EV, Fazal S, Shaw PJ, McDermott CJ. “Anything that makes life’s journey better.” exploring the use of digital technology by people living with motor neurone disease. Amyotr Later Scleros Frontotemp Degen. (2017) 18:378–87. doi: 10.1080/21678421.2017.1288253 PubMed DOI

Bertschek I, Kesler R. Let the user speak: is feedback on Facebook a source of firms’ innovation? Inf Econ Policy. (2022) 60:100991. doi: 10.1016/j.infoecopol.2022.100991 DOI

Masrori P, Van Damme P. Amyotrophic lateral sclerosis: a clinical review. Eur J Neurol. (2020) 27:1918–29. doi: 10.1111/ene.14393, PMID: PubMed DOI PMC

Feldman EL, Goutman SA, Petri S, Mazzini L, Savelieff MG, Shaw PJ, et al. . Amyotrophic lateral sclerosis. Lancet. (2022) 400:1363–80. doi: 10.1016/S0140-6736(22)01272-7, PMID: PubMed DOI PMC

Andrew AS, Bradley WG, Peipert D, Butt T, Amoako K, Pioro EP, et al. . Risk factors for amyotrophic lateral sclerosis: a regional United States case-control study. Muscle Nerve. (2021) 63:52–9. doi: 10.1002/mus.27085, PMID: PubMed DOI PMC

Turner MR, Talbot K. Primary lateral sclerosis: diagnosis and management. Pract Neurol. (2020) 20:262–9. doi: 10.1136/practneurol-2019-002300 PubMed DOI

Quinn C, Elman L. Amyotrophic lateral sclerosis and other motor neuron diseases. CONTINUUM Lifelong Learn Neurol. (2020) 26:1323–47. doi: 10.1212/CON.0000000000000911, PMID: PubMed DOI

Saberi S, Stauffer JE, Schulte DJ, Ravits J. Neuropathology of amyotrophic lateral sclerosis and its variants. Neurol Clin. (2015) 33:855–76. doi: 10.1016/j.ncl.2015.07.012, PMID: PubMed DOI PMC

Norris SP, Likanje M-FN, Andrews JA. Amyotrophic lateral sclerosis: update on clinical management. Curr Opin Neurol. (2020) 33:641–8. doi: 10.1097/WCO.0000000000000864, PMID: PubMed DOI

Madsen LS, Jeppesen J, Handberg C. “Understanding my ALS”. Experiences and reflections of persons with amyotrophic lateral sclerosis and relatives on participation in peer group rehabilitation. Disabil Rehabil. (2019) 41:1410–8. doi: 10.1080/09638288.2018.1429499, PMID: PubMed DOI

Kazmer MM, Lustria MLA, Cortese J, Burnett G, Kim J, Ma J, et al. . Distributed knowledge in an online patient support community: authority and discovery. J Assoc Inf Sci Technol. (2014) 65:1319–34. doi: 10.1002/asi.23064 DOI

Boostani R, Olfati N, Shamshiri H, Salimi Z, Fatehi F, Hedjazi SA, et al. . Iranian clinical practice guideline for amyotrophic lateral sclerosis. Front Neurol. (2023) 14:1154579. doi: 10.3389/fneur.2023.1154579, PMID: PubMed DOI PMC

Kong Z, Chen P, Jiang J, Wang X, Wang Y, Shi Y, et al. . Pain characteristics in amyotrophic lateral sclerosis patients and its impact on quality of life: a prospective observational study in a northern city of China. Ann Palliative Med. (2021) 10:1668–74. doi: 10.21037/apm-20-864, PMID: PubMed DOI

Oh J, Kim JA. Supportive care needs of patients with amyotrophic lateral sclerosis/motor neuron disease and their caregivers: a scoping review. J Clin Nurs. (2017) 26:4129–52. doi: 10.1111/jocn.13945, PMID: PubMed DOI

Andrews JA, Berry JD, Baloh RH, Carberry N, Cudkowicz ME, Dedi B, et al. . Amyotrophic lateral sclerosis care and research in the United States during the COVID-19 pandemic: challenges and opportunities. Muscle Nerve. (2020) 62:182–6. doi: 10.1002/mus.26989, PMID: PubMed DOI PMC

Brent JR, Franz CK, Coleman JM, Ajroud-Driss S. ALS. Neurol Clin. (2020) 38:565–75. doi: 10.1016/j.ncl.2020.03.013, PMID: PubMed DOI PMC

Hargreaves S, Bath PA, Duffin S, Ellis J. Sharing and empathy in digital spaces: qualitative study of online health forums for breast cancer and motor neuron disease (amyotrophic lateral sclerosis). J Med Internet Res. (2018) 20:e222. doi: 10.2196/jmir.9709, PMID: PubMed DOI PMC

Kenigsberg P-A, Aquino J-P, Bérard A, Brémond F, Charras K, Dening T, et al. . Assistive technologies to address capabilities of people with dementia: from research to practice. Dementia. (2019) 18:1568–95. doi: 10.1177/1471301217714093, PMID: PubMed DOI

Henschke C. Provision and financing of assistive technology devices in Germany: a bureaucratic odyssey? The case of amyotrophic lateral sclerosis and Duchenne muscular dystrophy. Health Policy. (2012) 105:176–84. doi: 10.1016/j.healthpol.2012.01.013, PMID: PubMed DOI

Londral A. Assistive technologies for communication empower patients with ALS to generate and self-report health data. Front Neurol. (2022) 13:867567. doi: 10.3389/fneur.2022.867567, PMID: PubMed DOI PMC

Peters B, O’Brien K, Fried-Oken M. A recent survey of augmentative and alternative communication use and service delivery experiences of people with amyotrophic lateral sclerosis in the United States. Disabil Rehabil Assist Technol. (2022) 19:1121–34. doi: 10.1080/17483107.2022.2149866, PMID: PubMed DOI

Funke A, Spittel S, Grehl T, Grosskreutz J, Kettemann D, Petri S, et al. . Provision of assistive technology devices among people with ALS in Germany: a platform-case management approach. Amyotr Later Scleros Frontotemporal Degen. (2018) 19:342–50. doi: 10.1080/21678421.2018.1431786, PMID: PubMed DOI

Ward AL, Hammond S, Holsten S, Bravver E, Brooks BR. Power wheelchair use in persons with amyotrophic lateral sclerosis: changes over time. Assist Technol. (2015) 27:238–45. doi: 10.1080/10400435.2015.1040896, PMID: PubMed DOI

Hansen-Flaschen J. Respiratory care for patients with amyotrophic lateral sclerosis in the US: in need of support. JAMA Neurol. (2021) 78:1047–8. doi: 10.1001/jamaneurol.2021.2400, PMID: PubMed DOI

Chen JJ. Overview of current and emerging therapies for amytrophic lateral sclerosis. Am J Manag Care. (2020) 26:S191–7. doi: 10.37765/ajmc.2020.88483, PMID: PubMed DOI

Goutman SA, Hardiman O, Al-Chalabi A, Chió A, Savelieff MG, Kiernan MC, et al. . Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis. Lancet Neurol. (2022) 21:480–93. doi: 10.1016/S1474-4422(21)00465-8, PMID: PubMed DOI PMC

Wang J, Xu S, Dai Y, Gao S. An eye tracking and brain-computer Interface based human-environment interactive system for amyotrophic lateral sclerosis patients. IEEE Sensors J. (2022) 23:24095–106. doi: 10.1109/JSEN.2022.3223878, PMID: PubMed DOI

Benbrika S, Desgranges B, Eustache F, Viader F. Cognitive, emotional and psychological manifestations in amyotrophic lateral sclerosis at baseline and overtime: a review. Front Neurosci. (2019) 13:951. doi: 10.3389/fnins.2019.00951, PMID: PubMed DOI PMC

Armstrong MJ, Alliance S. Virtual support groups for informal caregivers of individuals with dementia: a scoping review. Alzheimer Dis Assoc Disord. (2019) 33:362–9. doi: 10.1097/WAD.0000000000000349, PMID: PubMed DOI

Olesen LK, La Cour K, Thorne S, With H, Handberg C. Perceived benefits from peer-support among family caregivers of people with amyotrophic lateral sclerosis and cognitive impairments in a palliative rehabilitation blended online learning programme. J Eval Clin Pract. (2023) 29:602–13. doi: 10.1111/jep.13808, PMID: PubMed DOI

Davey S, Brennan M, Meenan BJ, McAdam R, Lilford R, Girling A, et al. . A framework to manage the early value proposition of emerging healthcare technologies. Ir J Manag. (2011) 31:60–75.

Antipova T. Need for high-tech medical devices in value-based health care. Institute of Certified Specialists (ICS) eBooks. (2022):50–62. doi: 10.33847/978-5-6048575-0-2_4 DOI

Hourd PC, Williams DJ. Success in healthcare technology businesses: coordinating the value milestones of new product introduction, financial stakeholders and business growth. Innovations. (2006) 8:229–47. doi: 10.5172/impp.2006.8.3.229 DOI

Yang Y, Yin Z. Resilience of a supply chain-based economic evaluation of medical devices from an industry perspective. Int J Data Warehousing Min. (2023) 19:1–18. doi: 10.4018/ijdwm.320761 DOI

Freier H, Gerhards LM, Sondern D, Schwenke S, Thielsch M. Usability and user experience of medical devices – insights from laypersons and healthcare professionals. Mensch Und Computer. (2022) 2022:328–32. doi: 10.1145/3543758.3547534 DOI

Yang F, Wang L, Ding X. Why Some ‘User-Centred’ Medical Devices do not Provide Satisfactory User Experiences? An Investigation on User Information Factors in New Device Development Processes. Lecture notes in computer science. (2022). 314–24. doi: 10.1007/978-3-031-05897-4_22 DOI

Obremskey WT, Dail T, Jahangir AA. Value-based purchasing of medical devices. Clin Orthopaed Relat Res. (2012) 470:1054–64. doi: 10.1007/s11999-011-2147-9, PMID: PubMed DOI PMC

Robinson JC. Value-based purchasing for medical devices. Health Aff. (2008) 27:1523–31. doi: 10.1377/hlthaff.27.6.1523 PubMed DOI

Perotti L, Klebbe R, Maier A, Eicher C. Evaluation of the quality and the provision process of wheelchairs in Germany. Results from an online survey. Disability and rehabilitation. Assist Technol. (2023) 18:205–14. doi: 10.1080/17483107.2020.1841837, PMID: PubMed DOI

Bombaci A, Abbadessa G, Trojsi F, Leocani L, Bonavita S, Lavorgna L, et al. . Telemedicine for management of patients with amyotrophic lateral sclerosis through COVID-19 tail. Neurol Sci. (2021) 42:9–13. doi: 10.1007/s10072-020-04783-x, PMID: PubMed DOI PMC

Pugliese R, Sala R, Regondi S, Beltrami B, Lunetta C. Emerging technologies for management of patients with amyotrophic lateral sclerosis: from telehealth to assistive robotics and neural interfaces. J Neurol. (2022) 269:2910–21. doi: 10.1007/s00415-022-10971-w, PMID: PubMed DOI PMC

Zhu Y, Xu Y, Xuan R, Huang J, István B, Fekete G, et al. . Mixed comparison of different exercise interventions for function, respiratory, fatigue, and quality of life in adults with amyotrophic lateral sclerosis: systematic review and network meta-analysis. Front Aging Neurosci. (2022) 14:919059. doi: 10.3389/fnagi.2022.919059, PMID: PubMed DOI PMC

Katzeff JS, Bright F, Phan K, Kril JJ, Ittner LM, Kassiou M, et al. . Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosis. Brain. (2022) 145:1598–609. doi: 10.1093/brain/awac077, PMID: PubMed DOI PMC

Savage M, Albala S, Seghers F, Kattel R, Liao C, Chaudron M, et al. . Applying market shaping approaches to increase access to assistive technology in low-and middle-income countries. Assist Technol. (2021) 33:124–35. doi: 10.1080/10400435.2021.1991050, PMID: PubMed DOI

Mallin SSV, Carvalho HGD. Assistive technology and user-centered design: emotion as element for innovation. Proc Manuf. (2015) 3:5570–8. doi: 10.1016/j.promfg.2015.07.738 DOI

Howard R, Gathercole R, Bradley R, Harper E, Davis L, Pank L, et al. . The effectiveness and cost-effectiveness of assistive technology and telecare for independent living in dementia: a randomised controlled trial. Age Ageing. (2021) 50:882–90. doi: 10.1093/ageing/afaa284, PMID: PubMed DOI PMC

Puli L, Layton N, Mont D, Shae K, Calvo I, Hill KD, et al. . Assistive technology provider experiences during the COVID-19 pandemic. Int J Environ Res Public Health. (2021) 18:10477. doi: 10.3390/ijerph181910477, PMID: PubMed DOI PMC

Yusif S, Soar J, Hafeez-Baig A. Older people, assistive technologies, and the barriers to adoption: a systematic review. Int J Med Inform. (2016) 94:112–6. doi: 10.1016/j.ijmedinf.2016.07.004, PMID: PubMed DOI

Govindarajan R, Berry JD, Paganoni S, Pulley MT, Simmons Z. Optimizing telemedicine to facilitate amyotrophic lateral sclerosis clinical trials. Muscle Nerve. (2020) 62:321–6. doi: 10.1002/mus.26921, PMID: PubMed DOI

Tangcharoensathien V, Witthayapipopsakul W, Viriyathorn S, Patcharanarumol W. Improving access to assistive technologies: challenges and solutions in low-and middle-income countries. WHO South East Asia J Public Health. (2018) 7:84–9. doi: 10.4103/2224-3151.239419, PMID: PubMed DOI

Vaz R, Freitas D, Coelho A. Blind and visually impaired visitors’ experiences in museums: increasing accessibility through assistive technologies. Int J Inclusive Museum. (2020) 13:57–80. doi: 10.18848/1835-2014/CGP/v13i02/57-80 DOI

Kaiser F, Wiens M, Schultmann F. Comparing the perception of privacy for medical devices and devices with medical functionality: international journal of privacy and health. Inf Manag. (2020) 8:52–69. doi: 10.4018/IJPHIM.2020010103 DOI

Shahid J, Ahmad R, Kiani AK, Ahmad T, Saeed S, Almuhaideb AM. Data protection and privacy of the internet of healthcare things (IoHTs). Appl Sci. (2022) 12:1927. doi: 10.3390/app12041927 DOI

Doughty K, Williams G. New models of assessment and prescription of smart assisted living technologies for personalised support of older and disabled people. J Assist Technol. (2016) 10:39–50. doi: 10.1108/JAT-01-2016-0003 DOI

Kruse CS, Fohn J, Umunnakwe G, Patel K, Patel S. Evaluating the facilitators, barriers, and medical outcomes commensurate with the use of assistive technology to support people with dementia: a systematic review literature. Healthcare. (2020) 8:278. doi: 10.3390/healthcare8030278, PMID: PubMed DOI PMC

Baumann L, Klösch M, Greger M, Dieplinger A, Lorenzl S. Amyotrophe Lateralsklerose – Herausforderungen von pflegenden Angehörigen. Fortschritte der Neurologie · Psychiatrie. (2019) 87:476–82. doi: 10.1055/a-0934-6163, PMID: PubMed DOI

Tinker A, Lansley P. Introducing assistive technology into the existing homes of older people: feasibility, acceptability, costs and outcomes. J Telemed Telecare. (2005) 11:1–3. doi: 10.1258/1357633054461787, PMID: PubMed DOI

Bachmann P. Caregivers’ experience of caring for a family member with Alzheimer’s disease: a content analysis of longitudinal social media communication. Int J Environ Res Public Health. (2020) 17:4412. doi: 10.3390/ijerph17124412, PMID: PubMed DOI PMC

Bareket-Bojmel L, Moran S, Shahar G. Strategic self-presentation on Facebook: personal motives and audience response to online behavior. Comput Hum Behav. (2016) 55:788–95. doi: 10.1016/j.chb.2015.10.033 DOI

Scott GG, Ravenscroft K. Bragging on Facebook: the interaction of content source and focus in online impression formation. Cyberpsychol Behav Soc Netw. (2017) 20:58–63. doi: 10.1089/cyber.2016.0311, PMID: PubMed DOI

Ralli M, Lambiase A, Artico M, de Vincentiis M, Greco A. Amyotrophic lateral sclerosis: autoimmune pathogenic mechanisms, clinical features, and therapeutic perspectives. Isr Med Assoc J IMAJ. (2019) 21:438–43. PMID: PubMed